Subscribe to Newsletter
Manufacture Clinical Trials, Drug Delivery, Quality & Compliance

Characterizing Liposomes for Drug Delivery

sponsored by Malvern Panalytical

Liposomes are fast becoming a preferred vehicle for delivering therapeutic drug molecules to target sites – meaning techniques to measure the size, concentration and zeta potential of the preparation are growing in importance

For a drug delivery vehicle to be successful, it will ideally localise and target the therapeutic agent to the site of interest and enable a measurable drug interaction with the affected tissue. Used increasingly for this purpose are liposomes, whose applications now include both systemic and topical drug delivery. With the capacity for formulation as liquids, solids or semi-solids, liposomes are being used in treatments ranging from targeting fungal infections to hepatitis A and acute lymphoblastic leukaemia.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine